feed,title,long_url,short_url
Benzinga,Silo Pharma Announces Collaboration with University California San Francisco to study Psilocybin as an Anti-Inflammatory agent in Parkinson's and Bipolar Patients,https://benzinga.com/news/21/06/21468944/silo-pharma-announces-collaboration-with-university-california-san-francisco-to-study-psilocybin-as,https://j.mp/3g33rnT
